packageEtretinate

etretinate

Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).

Information

Etretinate is a retinoid that was used as a systemic treatment for psoriasis and related skin conditions such as acropustulosis. It has been withdrawn from the market because, as a retinoid with developmental toxicity, it can cause severe birth defects and persists in the body for a long time.

Summary written by glm-5.3-flash from Wikidata Q554297 and the WHO ATC classification; not checked by a person.

name:etretinate
ATC codes:D05BB01
DrugBank:DB00926
PubChem CID:3312
ChEBI:4913
Wikidata:Q554297
formula:C23H30O3
molar mass:354.49 g/mol (PubChem CID 3312)
logP:6.8 (Drugs.Common 25.09, not verified)

Parameters

TypeNameDefaultDescription
Stringname (from PartialSubstance)""INN / common name
String[:]atcCodes (from PartialSubstance)fill("", 0)all WHO ATC codes of the drug
StringdrugbankId (from PartialSubstance)""e.g. DB00758
StringpubchemCid (from PartialSubstance)""PubChem compound id
StringchebiId (from PartialSubstance)""ChEBI id (number)
StringwikidataId (from PartialSubstance)""e.g. Q410238
Stringformula (from PartialSubstance)""molecular formula
Modelica.Units.SI.MolarMassM (from PartialSubstance)0molar mass; 0 = unknown
ReallogP (from PartialSubstance)Modelica.Constants.infoctanol-water partition coefficient (log10); inf = unknown